Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


12.04.2021

1 Antiviral Res
2 Biochem Biophys Res Commun
14 BMJ
2 Epidemiol Infect
5 Eur J Epidemiol
1 J Immunol
27 J Infect
1 J Infect Dis
3 J Virol
1 JAMA
5 Lancet
12 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
3 PLoS Biol
1 PLoS Comput Biol
71 PLoS One
1 Proc Natl Acad Sci U S A
7 Vaccine
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antiviral Res

  1. SALINAS FM, Nebreda AD, Vazquez L, Gentilini MV, et al
    Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
    Antiviral Res. 2020;179:104817.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  2. PEREIRA F
    SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.
    Biochem Biophys Res Commun. 2021;550:8-14.
    PubMed         Abstract available

  3. SHIBUYA M, Tamiya S, Kawai A, Yoshioka Y, et al
    Nasal-subcutaneous prime-boost regimen for inactivated whole-virus influenza vaccine efficiently protects mice against both upper and lower respiratory tract infections.
    Biochem Biophys Res Commun. 2021;554:166-172.
    PubMed         Abstract available


    BMJ

  4. GOLDSTEIN A
    Failure to achieve global vaccine equity will have dire consequences.
    BMJ. 2021;372:n712.
    PubMed        

  5. GREENHALGH T, Knight M, Inda-Kim M, Fulop NJ, et al
    Remote management of covid-19 using home pulse oximetry and virtual ward support.
    BMJ. 2021;372:n677.
    PubMed        

  6. DOUST JA, Bell KJL, Leeflang MMG, Dinnes J, et al
    Guidance for the design and reporting of studies evaluating the clinical performance of tests for present or past SARS-CoV-2 infection.
    BMJ. 2021;372:n568.
    PubMed        

  7. MONSIVAIS P, Thompson C, Astbury CC, Penney TL, et al
    Environmental approaches to promote healthy eating: Is ensuring affordability and availability enough?
    BMJ. 2021;372:n549.
    PubMed        

  8. NABAVI N
    Tomorrow's doctors, tomorrow's leaders.
    BMJ. 2021;372:n855.
    PubMed        

  9. SMITH LE, Potts HWW, Amlot R, Fear NT, et al
    Adherence to the test, trace, and isolate system in the UK: results from 37 nationally representative surveys.
    BMJ. 2021;372:n608.
    PubMed         Abstract available

  10. AYOUBKHANI D, Khunti K, Nafilyan V, Maddox T, et al
    Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study.
    BMJ. 2021;372:n693.
    PubMed         Abstract available

  11. OSAMA T, Razai MS, Majeed A
    Covid-19 vaccine passports: access, equity, and ethics.
    BMJ. 2021;373:n861.
    PubMed        

  12. MUGHAL F
    Covid-19 vaccination during Ramadan.
    BMJ. 2021;373:n862.
    PubMed        

  13. SIVAN M, Rayner C, Delaney B
    Fresh evidence of the scale and scope of long covid.
    BMJ. 2021;373:n853.
    PubMed        

  14. SCALLY G
    A new public health body for the UK.
    BMJ. 2021;373:n875.
    PubMed        

  15. CHENG HY, Cohen T, Lin HH
    Test, trace, and isolate in the UK.
    BMJ. 2021;372:n822.
    PubMed        


  16. Update to living systematic review on drug treatments for covid-19.
    BMJ. 2021;372:n858.
    PubMed        


  17. Update to living WHO guideline on drugs for covid-19.
    BMJ. 2021;372:n860.
    PubMed        


    Epidemiol Infect

  18. OGIMI C, Qu P, Boeckh M, Bender Ignacio RA, et al
    Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.
    Epidemiol Infect. 2021;149:e75.
    PubMed         Abstract available

  19. CAO Y, Wang Y, Das A, Pan CQ, et al
    Transmission dynamics of COVID-19 among index case family clusters in Beijing, China.
    Epidemiol Infect. 2020;149:e74.
    PubMed         Abstract available


    Eur J Epidemiol

  20. GIANICOLO EAL, Russo A, Buchler B, Taylor K, et al
    Gender specific excess mortality in Italy during the COVID-19 pandemic accounting for age.
    Eur J Epidemiol. 2021;36:213-218.
    PubMed         Abstract available

  21. CARRAT F, Figoni J, Henny J, Desenclos JC, et al
    Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.
    Eur J Epidemiol. 2021;36:219-222.
    PubMed         Abstract available

  22. ACCORSI EK, Qiu X, Rumpler E, Kennedy-Shaffer L, et al
    How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19.
    Eur J Epidemiol. 2021;36:179-196.
    PubMed         Abstract available

  23. SKJEFTE M, Ngirbabul M, Akeju O, Escudero D, et al
    COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries.
    Eur J Epidemiol. 2021;36:197-211.
    PubMed         Abstract available

  24. PEARCE N, Vandenbroucke JP
    Arguments about face masks and Covid-19 reflect broader methodologic debates within medical science.
    Eur J Epidemiol. 2021;36:143-147.
    PubMed         Abstract available


    J Immunol

  25. SOKULSKY LA, Garcia-Netto K, Nguyen TH, Girkin JLN, et al
    A Critical Role for the CXCL3/CXCL5/CXCR2 Neutrophilic Chemotactic Axis in the Regulation of Type 2 Responses in a Model of Rhinoviral-Induced Asthma Exacerbation.
    J Immunol. 2020 Sep 18. pii: jimmunol.1901350. doi: 10.4049/jimmunol.1901350.
    PubMed         Abstract available


    J Infect

  26. COLSON P, Finaud M, Levy N, Lagier JC, et al
    Evidence of SARS-CoV-2 re-infection with a different genotype.
    J Infect. 2020 Nov 15. pii: S0163-4453(20)30706.
    PubMed        

  27. HAMED E, Alnuaimi AS, Syed MA, Elhamid MA, et al
    Clinical characteristics of 51815 patients presenting with positive and negative SARS-CoV-2 swab results in primary health care settings.
    J Infect. 2020 Nov 13. pii: S0163-4453(20)30709.
    PubMed        

  28. RANA MS
    Clinical and laboratory characteristics of recovered versus deceased COVID-19 patients in Islamabad, Pakistan.
    J Infect. 2020 Nov 13. pii: S0163-4453(20)30705.
    PubMed        

  29. GARDINER T, Cooke G, Fidler S, Cooper N, et al
    The under-representation of BAME patients in the COVID-19 Recovery trial at a major London NHS Trust.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30699.
    PubMed        

  30. CHAN RWY, Chan KC, Chan KYY, Lui GCY, et al
    SARS-CoV-2 detection by nasal strips: a superior tool for surveillance of pediatric population.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30704.
    PubMed        

  31. YAN Y, Jiang X, Fu J, Huang J, et al
    Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30701.
    PubMed        

  32. JI J, Wu M, Zhong L, Liu Z, et al
    Early, low-dose, short-term methylprednisolone decreased the mortality in critical COVID-19 patients: a multicenter retrospective cohort study.
    J Infect. 2020 Nov 8. pii: S0163-4453(20)30696.
    PubMed        

  33. ROWLAND TAJ, Whitaker H, Jeffery-Smith A, Lang N, et al
    Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemic.
    J Infect. 2020 Nov 4. pii: S0163-4453(20)30695.
    PubMed        

  34. ALANIO A, Delliere S, Voicu S, Bretagne S, et al
    The presence of Pneumocystis jirovecii in critically ill patients with COVID-19.
    J Infect. 2020 Nov 4. pii: S0163-4453(20)30694.
    PubMed        

  35. SAITO S, Asai Y, Matsunaga N, Hayakawa K, et al
    First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics: Comparison of the two COVID-19 waves in Japan.
    J Infect. 2020 Nov 2. pii: S0163-4453(20)30693.
    PubMed        

  36. SCHIRINZI A, Pesce F, Laterza R, D'Alise MG, et al
    Pentraxin 3: potential prognostic role in SARS-CoV-2 patients admitted to the emergency department.
    J Infect. 2020 Nov 1. pii: S0163-4453(20)30687.
    PubMed        

  37. HAMED E
    Rates of recurrent positive SARS-CoV-2 swab results among patients attending primary care in Qatar.
    J Infect. 2020 Oct 31. pii: S0163-4453(20)30691.
    PubMed        

  38. TORRES M, Collins K, Corbit M, Ramirez M, et al
    Comparison of Saliva and Nasopharyngeal Swab SARS-CoV-2 RT-qPCR Testing in a Community Setting.
    J Infect. 2020 Nov 17. pii: S0163-4453(20)30710.
    PubMed        

  39. BAUER W, Diehl-Wiesenecker E, Ulke J, Galtung N, et al
    Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department.
    J Infect. 2020 Nov 17. pii: S0163-4453(20)30711.
    PubMed        

  40. TABOADA M, Carinena A, Moreno E, Rodriguez N, et al
    Post-COVID-19 functional status six-months after Hospitalization.: Functional status after COVID-19.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30784.
    PubMed        

  41. PETRONE L, Petruccioli E, Alonzi T, Vanini V, et al
    In-vitro evaluation of the immunomodulatory effects of baricitinib: implication for COVID-19 therapy.
    J Infect. 2021 Feb 24. pii: S0163-4453(21)00094.
    PubMed         Abstract available

  42. MENSAH AA, Sinnathamby M, Zaidi A, Coughlan L, et al
    SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: prospective, national observational cohort surveillance, July-December 2020, England.
    J Infect. 2021 Feb 24. pii: S0163-4453(21)00093.
    PubMed         Abstract available

  43. TANAKA A, Yamamoto S, Miyo K, Mizoue T, et al
    Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.
    J Infect. 2021 Jan 29. pii: S0163-4453(21)00032.
    PubMed        

  44. DE FRANCESCO MA, Poiesi C, Gargiulo F, Bonfanti C, et al
    Co-infection of Chlamydia pneumoniae and Mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features.
    J Infect. 2021 Jan 19. pii: S0163-4453(21)00031.
    PubMed        

  45. TANG JW, Toovey OTR, Harvey KN, Hui DDS, et al
    Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.
    J Infect. 2021 Jan 17. pii: S0163-4453(21)00030.
    PubMed        

  46. BREATHNACH DAS, Riley PA, Cotter MP, Houston AC, et al
    Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months.
    J Infect. 2021 Jan 12. pii: S0163-4453(21)00010.
    PubMed        

  47. BONGIOVANNI M, Bini F, Giuliani G, Gianturco L, et al
    Insight into the reason of prolonged viral RNA shedding in patients with COVID-19 infection.
    J Infect. 2021 Jan 3. pii: S0163-4453(21)00002.
    PubMed        

  48. LIU Y, Li M, Liu D, Luo JF, et al
    Developing a multivariable risk prediction model to predict prolonged viral clearance in patients with COVID-19.
    J Infect. 2020 Dec 30. pii: S0163-4453(20)30787.
    PubMed        

  49. TANG JW, Tambyah PA, Hui DS
    Emergence of a new SARS-CoV-2 variant in the UK.
    J Infect. 2020 Dec 28. pii: S0163-4453(20)30786.
    PubMed        

  50. YANG H, Xu J, Liang X, Shi L, et al
    Autoimmune diseases are independently associated with COVID-19 severity: Evidence based on adjusted effect estimates.
    J Infect. 2020 Dec 28. pii: S0163-4453(20)30785.
    PubMed        

  51. HANRATH AT, Payne BAI, Duncan CJA, van der Loeff IS, et al
    Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30781.
    PubMed        

  52. CHAN HT, Chao CM, Lai CC
    Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: a meta-analysis.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30783.
    PubMed        


    J Infect Dis

  53. SATO M, Takashita E, Katayose M, Nemoto K, et al
    Detection of variants with reduced baloxavir marboxil and oseltamivir susceptibility in children with influenza A during the 2019-2020 influenza season.
    J Infect Dis. 2021 Apr 10. pii: 6219607. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  54. MORI K, Ohniwa RL, Takizawa N, Naito T, et al
    Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain using an Engineered High-Fidelity Viral Polymerase.
    J Virol. 2021 Apr 7. pii: JVI.00493-21. doi: 10.1128/JVI.00493.
    PubMed         Abstract available

  55. ZHENG J, Wen L, Yen HL, Liu M, et al
    Phenotypic and functional characteristics of a novel influenza hemagglutinin-specific memory NK cell.
    J Virol. 2021 Apr 7. pii: JVI.00165-21. doi: 10.1128/JVI.00165.
    PubMed         Abstract available

  56. ZHANG H, Zheng H, Guo P, Hu L, et al
    Broadly protective CD8(+) T cell immunity to highly conserved epitopes elicited by heat shock protein gp96-adjuvanted influenza monovalent split vaccine.
    J Virol. 2021 Apr 7. pii: JVI.00507-21. doi: 10.1128/JVI.00507.
    PubMed         Abstract available


    JAMA

  57. MEHTA A
    "Self-Portrait as Exit Wounds": A Graphic Story.
    JAMA. 2021;325:1127-1129.
    PubMed        


    Lancet

  58. PRENDECKI M, Clarke C, Brown J, Cox A, et al
    Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.
    Lancet. 2021 Feb 25. pii: S0140-6736(21)00502.
    PubMed        

  59. GURDASANI D, Alwan NA, Greenhalgh T, Hyde Z, et al
    School reopening without robust COVID-19 mitigation risks accelerating the pandemic.
    Lancet. 2021 Mar 10. pii: S0140-6736(21)00622.
    PubMed        

  60. KARIM SSA
    Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00468.
    PubMed        

  61. BOUM Y, Bebell LM, Bisseck AZ
    Africa needs local solutions to face the COVID-19 pandemic.
    Lancet. 2021;397:1238-1240.
    PubMed        

  62. LOTTA G, Fernandez M, Pimenta D, Wenham C, et al
    Gender, race, and health workers in the COVID-19 pandemic.
    Lancet. 2021;397:1264.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  63. VAHRATIAN A, Blumberg SJ, Terlizzi EP, Schiller JS, et al
    Symptoms of Anxiety or Depressive Disorder and Use of Mental Health Care Among Adults During the COVID-19 Pandemic - United States, August 2020-February 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:490-494.
    PubMed         Abstract available

  64. THOMPSON MG, Burgess JL, Naleway AL, Tyner HL, et al
    Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-Ma
    MMWR Morb Mortal Wkly Rep. 2021;70:495-500.
    PubMed         Abstract available

  65. HERSHOW RB, Segaloff HE, Shockey AC, Florek KR, et al
    Rapid Spread of SARS-CoV-2 in a State Prison After Introduction by Newly Transferred Incarcerated Persons - Wisconsin, August 14-October 22, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:478-482.
    PubMed         Abstract available

  66. LEE FC, Adams L, Graves SJ, Massetti GM, et al
    Counties with High COVID-19 Incidence and Relatively Large Racial and Ethnic Minority Populations - United States, April 1-December 22, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:483-489.
    PubMed         Abstract available

  67. LEWIS NM, Salmanson AP, Price A, Risk I, et al
    Community-Associated Outbreak of COVID-19 in a Correctional Facility - Utah, September 2020-January 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:467-472.
    PubMed         Abstract available

  68. SAMI S, Turbyfill CR, Daniel-Wayman S, Shonkwiler S, et al
    Community Transmission of SARS-CoV-2 Associated with a Local Bar Opening Event - Illinois, February 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:528-532.
    PubMed         Abstract available

  69. GUNDLAPALLI AV, Lavery AM, Boehmer TK, Beach MJ, et al
    Death Certificate-Based ICD-10 Diagnosis Codes for COVID-19 Mortality Surveillance - United States, January-December 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:523-527.
    PubMed         Abstract available


  70. QuickStats: Age-Adjusted Percentage* of Adults Aged >/=18 Years Who Had an Influenza Vaccination in the Past 12 Months,(dagger) by Sex and Race/Ethnicity( section sign) - National Health Interview Survey, United States, 2019( paragraph sign).
    MMWR Morb Mortal Wkly Rep. 2021;70:536.
    PubMed        

  71. PRATT CQ, Chard AN, LaPine R, Galbreath KW, et al
    Use of Stay-at-Home Orders and Mask Mandates to Control COVID-19 Transmission - Blackfeet Tribal Reservation, Montana, June-December 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:514-518.
    PubMed         Abstract available

  72. WILLIAMSON LL, Harwell TS, Koch TM, Anderson SL, et al
    COVID-19 Incidence and Mortality Among American Indian/Alaska Native and White Persons - Montana, March 13-November 30, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:510-513.
    PubMed         Abstract available

  73. AHMAD FB, Cisewski JA, Minino A, Anderson RN, et al
    Provisional Mortality Data - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:519-522.
    PubMed         Abstract available

  74. STERN MF, Piasecki AM, Strick LB, Rajeshwar P, et al
    Willingness to Receive a COVID-19 Vaccination Among Incarcerated or Detained Persons in Correctional and Detention Facilities - Four States, September-December 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:473-477.
    PubMed         Abstract available


    N Engl J Med

  75. BLUMENTHAL KG, Freeman EE, Saff RR, Robinson LB, et al
    Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMc2102131.
    PubMed        


    PLoS Biol

  76. REVERBY SM
    Racism, disease, and vaccine refusal: People of color are dying for access to COVID-19 vaccines.
    PLoS Biol. 2021;19:e3001167.
    PubMed         Abstract available

  77. MACLEAN OA, Lytras S, Weaver S, Singer JB, et al
    Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen.
    PLoS Biol. 2021;19:e3001115.
    PubMed         Abstract available

  78. KIM KS, Ejima K, Iwanami S, Fujita Y, et al
    A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
    PLoS Biol. 2021;19:e3001128.
    PubMed         Abstract available


    PLoS Comput Biol

  79. DI LAURO F, Kiss IZ, Miller JC
    Optimal timing of one-shot interventions for epidemic control.
    PLoS Comput Biol. 2021;17:e1008763.
    PubMed         Abstract available


    PLoS One

  80. PARANJAPE N, Staples LL, Stradwick CY, Ray HG, et al
    Development and validation of a predictive model for critical illness in adult patients requiring hospitalization for COVID-19.
    PLoS One. 2021;16:e0248891.
    PubMed         Abstract available

  81. LABIRIS G, Panagiotopoulou EK, Perente A, Chatzimichael E, et al
    Determinants of compliance to the facemask directive in Greece: A population study.
    PLoS One. 2021;16:e0248929.
    PubMed         Abstract available

  82. HOFER CK, Wendel Garcia PD, Heim C, Ganter MT, et al
    Analysis of anaesthesia services to calculate national need and supply of anaesthetics in Switzerland during the COVID-19 pandemic.
    PLoS One. 2021;16:e0248997.
    PubMed         Abstract available

  83. IAVICOLI S, Boccuni F, Buresti G, Gagliardi D, et al
    Risk assessment at work and prevention strategies on COVID-19 in Italy.
    PLoS One. 2021;16:e0248874.
    PubMed         Abstract available

  84. QUAAS MF, Meya JN, Schenk H, Bos B, et al
    The social cost of contacts: Theory and evidence for the first wave of the COVID-19 pandemic in Germany.
    PLoS One. 2021;16:e0248288.
    PubMed         Abstract available

  85. ZAFERANI ARANI H, Dehghan Manshadi G, Atashi HA, Rezaei Nejad A, et al
    Understanding the clinical and demographic characteristics of second coronavirus spike in 192 patients in Tehran, Iran: A retrospective study.
    PLoS One. 2021;16:e0246314.
    PubMed         Abstract available

  86. ZHU Y, Zhang J, Li Y, Liu F, et al
    Association between thrombocytopenia and 180-day prognosis of COVID-19 patients in intensive care units: A two-center observational study.
    PLoS One. 2021;16:e0248671.
    PubMed         Abstract available

  87. HU C, Li J, Xing X, Gao J, et al
    The effect of age on the clinical and immune characteristics of critically ill patients with COVID-19: A preliminary report.
    PLoS One. 2021;16:e0248675.
    PubMed         Abstract available

  88. HAMMAD MA, Alqarni TM
    Psychosocial effects of social media on the Saudi society during the Coronavirus Disease 2019 pandemic: A cross-sectional study.
    PLoS One. 2021;16:e0248811.
    PubMed         Abstract available

  89. ALABYAD D, Rangaraju S, Liu M, Imran R, et al
    Validation of an admission coagulation panel for risk stratification of COVID-19 patients.
    PLoS One. 2021;16:e0248230.
    PubMed         Abstract available

  90. DEVKOTA HR, Sijali TR, Bogati R, Ahmad M, et al
    The impact of COVID-19 on mental health outcomes among hospital fever clinic attendants across Nepal: A cross-sectional study.
    PLoS One. 2021;16:e0248684.
    PubMed         Abstract available

  91. ZOU JN, Sun L, Wang BR, Zou Y, et al
    The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT.
    PLoS One. 2021;16:e0248957.
    PubMed         Abstract available

  92. UMAIR M, Ikram A, Salman M, Khurshid A, et al
    Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan.
    PLoS One. 2021;16:e0248371.
    PubMed         Abstract available

  93. ALENE M, Yismaw L, Assemie MA, Ketema DB, et al
    Magnitude of asymptomatic COVID-19 cases throughout the course of infection: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0249090.
    PubMed         Abstract available

  94. ANDRES M, Leon-Ramirez JM, Moreno-Perez O, Sanchez-Paya J, et al
    Fatality and risk features for prognosis in COVID-19 according to the care approach - a retrospective cohort study.
    PLoS One. 2021;16:e0248869.
    PubMed         Abstract available

  95. SANTI L, Golinelli D, Tampieri A, Farina G, et al
    Non-COVID-19 patients in times of pandemic: Emergency department visits, hospitalizations and cause-specific mortality in Northern Italy.
    PLoS One. 2021;16:e0248995.
    PubMed         Abstract available

  96. BLACKBERG A, Fernstrom N, Sarbrant E, Rasmussen M, et al
    Antibody kinetics and clinical course of COVID-19 a prospective observational study.
    PLoS One. 2021;16:e0248918.
    PubMed         Abstract available

  97. PROMPETCHARA E, Ketloy C, Tharakhet K, Kaewpang P, et al
    DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice.
    PLoS One. 2021;16:e0248007.
    PubMed         Abstract available

  98. PECORARO F, Luzi D, Clemente F
    The efficiency in the ordinary hospital bed management: A comparative analysis in four European countries before the COVID-19 outbreak.
    PLoS One. 2021;16:e0248867.
    PubMed         Abstract available

  99. LIMA LL, Atman APF
    Impact of mobility restriction in COVID-19 superspreading events using agent-based model.
    PLoS One. 2021;16:e0248708.
    PubMed         Abstract available

  100. DE SOUZA FSH, Hojo-Souza NS, Batista BDO, da Silva CM, et al
    On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database.
    PLoS One. 2021;16:e0248580.
    PubMed         Abstract available

  101. ASHINYO ME, Dubik SD, Duti V, Amegah KE, et al
    Infection prevention and control compliance among exposed healthcare workers in COVID-19 treatment centers in Ghana: A descriptive cross-sectional study.
    PLoS One. 2021;16:e0248282.
    PubMed         Abstract available

  102. FORNILI M, Petri D, Berrocal C, Fiorentino G, et al
    Psychological distress in the academic population and its association with socio-demographic and lifestyle characteristics during COVID-19 pandemic lockdown: Results from a large multicenter Italian study.
    PLoS One. 2021;16:e0248370.
    PubMed         Abstract available

  103. REYES LM, Ortiz L, Abedi M, Luciano Y, et al
    Misinformation on COVID-19 origin and its relationship with perception and knowledge about social distancing: A cross-sectional study.
    PLoS One. 2021;16:e0248160.
    PubMed         Abstract available

  104. BARRAGAN RC, Oliveira N, Khalvati K, Brooks R, et al
    Identifying with all humanity predicts cooperative health behaviors and helpful responding during COVID-19.
    PLoS One. 2021;16:e0248234.
    PubMed         Abstract available

  105. PAGLIARO S, Sacchi S, Pacilli MG, Brambilla M, et al
    Trust predicts COVID-19 prescribed and discretionary behavioral intentions in 23 countries.
    PLoS One. 2021;16:e0248334.
    PubMed         Abstract available

  106. NEERUKONDA SN, Vassell R, Herrup R, Liu S, et al
    Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2.
    PLoS One. 2021;16:e0248348.
    PubMed         Abstract available

  107. LI Y, Scherer N, Felix L, Kuper H, et al
    Prevalence of depression, anxiety and post-traumatic stress disorder in health care workers during the COVID-19 pandemic: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0246454.
    PubMed         Abstract available

  108. IBARRA-NAVA I, Flores-Rodriguez KG, Ruiz-Herrera V, Ochoa-Bayona HC, et al
    Ethnic disparities in COVID-19 mortality in Mexico: A cross-sectional study based on national data.
    PLoS One. 2021;16:e0239168.
    PubMed         Abstract available

  109. PICCOLI L, Dzankic J, Ruedin D
    Citizenship, Migration and Mobility in a Pandemic (CMMP): A global dataset of COVID-19 restrictions on human movement.
    PLoS One. 2021;16:e0248066.
    PubMed         Abstract available

  110. MERSHA A, Shibiru S, Girma M, Ayele G, et al
    Health professionals practice and associated factors towards precautionary measures for COVID-19 pandemic in public health facilities of Gamo zone, southern Ethiopia: A cross-sectional study.
    PLoS One. 2021;16:e0248272.
    PubMed         Abstract available

  111. ANAND NM, Liya DH, Pradhan AK, Tayal N, et al
    A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing.
    PLoS One. 2021;16:e0248553.
    PubMed         Abstract available

  112. MCELLISTREM MC, Clancy CJ, Buehrle DJ, Singh N, et al
    SARS-CoV-2 is associated with high viral loads in asymptomatic and recently symptomatic healthcare workers.
    PLoS One. 2021;16:e0248347.
    PubMed         Abstract available

  113. LI M, Wang Y, Ndiwane N, Orner MB, et al
    The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.
    PLoS One. 2021;16:e0248652.
    PubMed         Abstract available

  114. HU B, Dehmer M, Emmert-Streib F, Zhang B, et al
    Analysis of the real number of infected people by COVID-19: A system dynamics approach.
    PLoS One. 2021;16:e0245728.
    PubMed         Abstract available

  115. POUW N, van de Maat J, Veerman K, Ten Oever J, et al
    Clinical characteristics and outcomes of 952 hospitalized COVID-19 patients in The Netherlands: A retrospective cohort study.
    PLoS One. 2021;16:e0248713.
    PubMed         Abstract available

  116. KAJITANI Y, Hatayama M
    Explaining the effective reproduction number of COVID-19 through mobility and enterprise statistics: Evidence from the first wave in Japan.
    PLoS One. 2021;16:e0247186.
    PubMed         Abstract available

  117. GULBAY M, Ozbay BO, Mendi BAR, Bastug A, et al
    A CT radiomics analysis of COVID-19-related ground-glass opacities and consolidation: Is it valuable in a differential diagnosis with other atypical pneumonias?
    PLoS One. 2021;16:e0246582.
    PubMed         Abstract available

  118. KLINE JA, Camargo CA Jr, Courtney DM, Kabrhel C, et al
    Clinical prediction rule for SARS-CoV-2 infection from 116 U.S. emergency departments 2-22-2021.
    PLoS One. 2021;16:e0248438.
    PubMed         Abstract available

  119. RUMAIN B, Schneiderman M, Geliebter A
    Prevalence of COVID-19 in adolescents and youth compared with older adults in states experiencing surges.
    PLoS One. 2021;16:e0242587.
    PubMed         Abstract available

  120. PUWANANT S, Sinphurmsukskul S, Krailak L, Nakaviroj P, et al
    The impact of the coronavirus disease and Tele-Heart Failure Clinic on cardiovascular mortality and heart failure hospitalization in ambulatory patients with heart failure.
    PLoS One. 2021;16:e0249043.
    PubMed         Abstract available

  121. FELDMAN O, Samuel N, Kvatinsky N, Idelman R, et al
    Endotracheal intubation of COVID-19 patients by paramedics using a box barrier: A randomized crossover manikin study.
    PLoS One. 2021;16:e0248383.
    PubMed         Abstract available

  122. MCPADDEN J, Warner F, Young HP, Hurley NC, et al
    Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection.
    PLoS One. 2021;16:e0243291.
    PubMed         Abstract available

  123. UPSHAW TL, Brown C, Smith R, Perri M, et al
    Social determinants of COVID-19 incidence and outcomes: A rapid review.
    PLoS One. 2021;16:e0248336.
    PubMed         Abstract available

  124. FIORE VG, DeFelice N, Glicksberg BS, Perl O, et al
    Containment of COVID-19: Simulating the impact of different policies and testing capacities for contact tracing, testing, and isolation.
    PLoS One. 2021;16:e0247614.
    PubMed         Abstract available

  125. ASAI Y, Nguyen P, Hanna TP
    Impact of the COVID-19 pandemic on skin cancer diagnosis: A population-based study.
    PLoS One. 2021;16:e0248492.
    PubMed         Abstract available

  126. IFTIMIE S, Lopez-Azcona AF, Vallverdu I, Hernandez-Flix S, et al
    First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain.
    PLoS One. 2021;16:e0248029.
    PubMed         Abstract available

  127. WUNDERLICH F, Weigelt M, Rein R, Memmert D, et al
    How does spectator presence affect football? Home advantage remains in European top-class football matches played without spectators during the COVID-19 pandemic.
    PLoS One. 2021;16:e0248590.
    PubMed         Abstract available

  128. INBARAJ LR, George CE, Chandrasingh S
    Seroprevalence of COVID-19 infection in a rural district of South India: A population-based seroepidemiological study.
    PLoS One. 2021;16:e0249247.
    PubMed         Abstract available

  129. OLEZENE CS, Hansen E, Steere HK, Giacino JT, et al
    Functional outcomes in the inpatient rehabilitation setting following severe COVID-19 infection.
    PLoS One. 2021;16:e0248824.
    PubMed         Abstract available

  130. LUSCZEK ER, Ingraham NE, Karam BS, Proper J, et al
    Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles.
    PLoS One. 2021;16:e0248956.
    PubMed         Abstract available

  131. ASPACHS O, Durante R, Graziano A, Mestres J, et al
    Tracking the impact of COVID-19 on economic inequality at high frequency.
    PLoS One. 2021;16:e0249121.
    PubMed         Abstract available

  132. VERBERK JDM, Anthierens SA, Tonkin-Crine S, Goossens H, et al
    Experiences and needs of persons living with a household member infected with SARS-CoV-2: A mixed method study.
    PLoS One. 2021;16:e0249391.
    PubMed         Abstract available

  133. WENDT CH, Castro-Pearson S, Proper J, Pett S, et al
    Metabolite profiles associated with disease progression in influenza infection.
    PLoS One. 2021;16:e0247493.
    PubMed         Abstract available

  134. SAEED BQ, Al-Shahrabi R, Bolarinwa OA
    Socio-demographic correlate of knowledge and practice toward COVID-19 among people living in Mosul-Iraq: A cross-sectional study.
    PLoS One. 2021;16:e0249310.
    PubMed         Abstract available

  135. MARGRAF J, Brailovskaia J, Schneider S
    Adherence to behavioral Covid-19 mitigation measures strongly predicts mortality.
    PLoS One. 2021;16:e0249392.
    PubMed         Abstract available

  136. MALIK J, Malik A, Javaid M, Zahid T, et al
    Thyroid function analysis in COVID-19: A retrospective study from a single center.
    PLoS One. 2021;16:e0249421.
    PubMed         Abstract available

  137. ZALAT MM, Hamed MS, Bolbol SA
    The experiences, challenges, and acceptance of e-learning as a tool for teaching during the COVID-19 pandemic among university medical staff.
    PLoS One. 2021;16:e0248758.
    PubMed         Abstract available

  138. MOTTA LP, Silva PPFD, Borguezan BM, Amaral JLMD, et al
    An emergency system for monitoring pulse oximetry, peak expiratory flow, and body temperature of patients with COVID-19 at home: Development and preliminary application.
    PLoS One. 2021;16:e0247635.
    PubMed         Abstract available

  139. ZHONG L
    A dynamic pandemic model evaluating reopening strategies amid COVID-19.
    PLoS One. 2021;16:e0248302.
    PubMed         Abstract available

  140. ZUCKERMAN NS, Bucris E, Drori Y, Erster O, et al
    Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel.
    PLoS One. 2021;16:e0243265.
    PubMed         Abstract available

  141. KAELEN S, van den Boogaard W, Pellecchia U, Spiers S, et al
    How to bring residents' psychosocial well-being to the heart of the fight against Covid-19 in Belgian nursing homes-A qualitative study.
    PLoS One. 2021;16:e0249098.
    PubMed         Abstract available

  142. TEMESGEN K, Wakgari N, Debelo BT, Tafa B, et al
    Maternal health care services utilization amidstCOVID-19 pandemic in West Shoa zone, central Ethiopia.
    PLoS One. 2021;16:e0249214.
    PubMed         Abstract available

  143. NIJMAN G, Wientjes M, Ramjith J, Janssen N, et al
    Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis.
    PLoS One. 2021;16:e0249231.
    PubMed         Abstract available

  144. ALBOKSMATY A, Kumar S, Parekh R, Aylin P, et al
    Management and patient safety of complex elderly patients in primary care during the COVID-19 pandemic in the UK-Qualitative assessment.
    PLoS One. 2021;16:e0248387.
    PubMed         Abstract available

  145. ARIAS-REYES C, Carvajal-Rodriguez F, Poma-Machicao L, Aliaga-Raduan F, et al
    Decreased incidence, virus transmission capacity, and severity of COVID-19 at altitude on the American continent.
    PLoS One. 2021;16:e0237294.
    PubMed         Abstract available

  146. WANG F, Tan Z, Yu Z, Yao S, et al
    Transmission and control pressure analysis of the COVID-19 epidemic situation using multisource spatio-temporal big data.
    PLoS One. 2021;16:e0249145.
    PubMed         Abstract available

  147. LEE T, Kwon HD, Lee J
    The effect of control measures on COVID-19 transmission in South Korea.
    PLoS One. 2021;16:e0249262.
    PubMed         Abstract available

  148. ANSAH JP, Matchar DB, Shao Wei SL, Low JG, et al
    The effectiveness of public health interventions against COVID-19: Lessons from the Singapore experience.
    PLoS One. 2021;16:e0248742.
    PubMed         Abstract available

  149. POSEL D, Oyenubi A, Kollamparambil U
    Job loss and mental health during the COVID-19 lockdown: Evidence from South Africa.
    PLoS One. 2021;16:e0249352.
    PubMed         Abstract available

  150. STUURMAN AL, Rizzo C, Haag M
    Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe.
    PLoS One. 2021;16:e0248943.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  151. CONLEY D, Johnson T
    Opinion: Past is future for the era of COVID-19 research in the social sciences.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed        


    Vaccine

  152. DRISCOLL AJ, Arshad SH, Bont L, Brunwasser SM, et al
    Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting.
    Vaccine. 2020;38:2435-2448.
    PubMed         Abstract available

  153. SAMY N, Reichhardt D, Schmidt D, Chen LM, et al
    Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial.
    Vaccine. 2020 Feb 11. pii: S0264-410X(20)30081.
    PubMed         Abstract available

  154. MUELLER S, Stauft CB, Kalkeri R, Koidei F, et al
    A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates.
    Vaccine. 2020 Feb 24. pii: S0264-410X(20)30279.
    PubMed         Abstract available

  155. FELL DB, Dimitris MC, Hutcheon JA, Ortiz JR, et al
    Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy.
    Vaccine. 2021 Mar 2. pii: S0264-410X(21)00261.
    PubMed         Abstract available

  156. PULLAN S, Dey M
    Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00287.
    PubMed         Abstract available

  157. PELTON SI, Divino V, Postma MJ, Shah D, et al
    A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.
    Vaccine. 2021 Mar 30. pii: S0264-410X(21)00347.
    PubMed         Abstract available

  158. WANG J, Lyu Y, Zhang H, Jing R, et al
    Willingness to pay and financing preferences for COVID-19 vaccination in China.
    Vaccine. 2021 Feb 27. pii: S0264-410X(21)00240.
    PubMed         Abstract available


    Virus Res

  159. HU Z, Zhao J, Shi L, Hu J, et al
    Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus.
    Virus Res. 2021;298:198409.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: